Vijaya Diagnostic Centre Limited (NSE:VIJAYA)
India
· Delayed Price · Currency is INR 975.00
+3.00 (0.31%)
Jun 6, 2025, 3:30 PM IST
Vijaya Diagnostic Centre Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2019 - 2020 |
| Revenue | 6,814 | 5,478 | 4,592 | 4,624 | 3,767 | Upgrade
|
| Revenue Growth (YoY) | 24.39% | 19.29% | -0.68% | 22.73% | 11.19% | Upgrade
|
| Cost of Revenue | 847.64 | 863.73 | 764.66 | 847.93 | 673.34 | Upgrade
|
| Gross Profit | 5,966 | 4,614 | 3,828 | 3,776 | 3,094 | Upgrade
|
| Selling, General & Admin | 1,122 | 985.79 | 846.63 | 758.93 | 612.4 | Upgrade
|
| Other Operating Expenses | 2,113 | 1,420 | 1,161 | 979.87 | 818.65 | Upgrade
|
| Operating Expenses | 3,940 | 2,975 | 2,624 | 2,266 | 1,939 | Upgrade
|
| Operating Income | 2,026 | 1,639 | 1,203 | 1,510 | 1,155 | Upgrade
|
| Interest Expense | -267.44 | -219.62 | -194.25 | -152.15 | -135.09 | Upgrade
|
| Interest & Investment Income | - | 59.73 | 82.8 | 97.99 | 95.96 | Upgrade
|
| Other Non Operating Income (Expenses) | 183.2 | -16.65 | -13.58 | -9.32 | -16.72 | Upgrade
|
| EBT Excluding Unusual Items | 1,942 | 1,462 | 1,078 | 1,447 | 1,099 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 124.76 | 47.19 | 18.39 | 4.86 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 19.52 | 0.86 | 3.98 | 1.56 | Upgrade
|
| Other Unusual Items | -10.3 | -19.95 | 9 | 2.14 | 15.44 | Upgrade
|
| Pretax Income | 1,932 | 1,587 | 1,135 | 1,474 | 1,121 | Upgrade
|
| Income Tax Expense | 493.71 | 390.44 | 283.03 | 367.17 | 269.97 | Upgrade
|
| Earnings From Continuing Operations | 1,438 | 1,196 | 852.07 | 1,107 | 851.27 | Upgrade
|
| Minority Interest in Earnings | -7.18 | -8.12 | -5.75 | -9.87 | -6.48 | Upgrade
|
| Net Income | 1,431 | 1,188 | 846.32 | 1,097 | 844.78 | Upgrade
|
| Net Income to Common | 1,431 | 1,188 | 846.32 | 1,097 | 844.78 | Upgrade
|
| Net Income Growth | 20.41% | 40.40% | -22.84% | 29.83% | 35.08% | Upgrade
|
| Shares Outstanding (Basic) | 103 | 102 | 102 | 102 | 102 | Upgrade
|
| Shares Outstanding (Diluted) | 103 | 103 | 102 | 103 | 102 | Upgrade
|
| Shares Change (YoY) | 0.26% | 0.03% | -0.08% | 0.57% | -0.02% | Upgrade
|
| EPS (Basic) | 13.95 | 11.62 | 8.29 | 10.76 | 8.28 | Upgrade
|
| EPS (Diluted) | 13.92 | 11.59 | 8.26 | 10.69 | 8.28 | Upgrade
|
| EPS Growth | 20.10% | 40.31% | -22.73% | 29.11% | 35.07% | Upgrade
|
| Free Cash Flow | 1,289 | 953.37 | 397.69 | 356.5 | 975.06 | Upgrade
|
| Free Cash Flow Per Share | 12.54 | 9.30 | 3.88 | 3.48 | 9.56 | Upgrade
|
| Dividend Per Share | 2.000 | 1.000 | 1.000 | 1.000 | - | Upgrade
|
| Dividend Growth | 100.00% | - | - | - | - | Upgrade
|
| Gross Margin | 87.56% | 84.23% | 83.35% | 81.66% | 82.13% | Upgrade
|
| Operating Margin | 29.74% | 29.92% | 26.20% | 32.66% | 30.66% | Upgrade
|
| Profit Margin | 21.00% | 21.69% | 18.43% | 23.72% | 22.42% | Upgrade
|
| Free Cash Flow Margin | 18.92% | 17.40% | 8.66% | 7.71% | 25.88% | Upgrade
|
| EBITDA | 2,732 | 1,930 | 1,581 | 1,846 | 1,491 | Upgrade
|
| EBITDA Margin | 40.10% | 35.23% | 34.44% | 39.92% | 39.57% | Upgrade
|
| D&A For EBITDA | 705.97 | 291.19 | 378.31 | 335.58 | 335.67 | Upgrade
|
| EBIT | 2,026 | 1,639 | 1,203 | 1,510 | 1,155 | Upgrade
|
| EBIT Margin | 29.74% | 29.92% | 26.20% | 32.66% | 30.66% | Upgrade
|
| Effective Tax Rate | 25.56% | 24.61% | 24.93% | 24.91% | 24.08% | Upgrade
|
| Revenue as Reported | 6,997 | 5,686 | 4,734 | 4,752 | 3,886 | Upgrade
|
| Advertising Expenses | - | 35.51 | 23.78 | 29.17 | 17.64 | Upgrade
|
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.